West Pharmaceutical Services Inc.
Last updated September 27, 2026
Organization details
- Legal name
- West Pharmaceutical Services Inc.
- Former names
- West Co Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Pennsylvania
- Headquarters city
- Exton
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- WST
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000105770
- EIN
- 23-1210010
Board of directors
-
Deborah L. Keller · DirectorSince 2023
-
Douglas A. Michels · DirectorSince 2023
-
Eric Mark Green · Director · President, CEO and Board ChairSince 2023
-
Goldman Myla Lai · DirectorSince 2023
-
Janet Brutschea Haugen · DirectorSince 2024
-
Mark A. Buthman · DirectorSince 2023
-
Michel Lagarde · Director · President and CEOSince 2026
-
Molly Joseph · DirectorSince 2023
-
Paolo Pucci · DirectorSince 2023
-
Robert F. Friel · DirectorSince 2023
-
Stephen H. Lockhart · DirectorSince 2023
-
Thomas W. Hofmann · DirectorSince 2023
-
William F. Feehery · DirectorSince 2023
Chief executives
Michel Lagarde
· President and CEO
Since August 2026
Eric Mark Green
· President, CEO and Board Chair
Until August 2026
· Former
Director election results
Annual meeting of May 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.2%
-
92.8%
-
94.3%
-
96.1%
-
96.3%
-
96.9%
-
97.6%
-
97.6%
-
98.5%
-
99.3%
Board connections
10 of this board's directors also sit on 13 other boards.
- via Janet Brutschea Haugen
- via William F. Feehery
- via Eric Mark Green
- via Molly Joseph
- via Mark A. Buthman
- via Molly Joseph
- via Stephen H. Lockhart
- via Janet Brutschea Haugen
- via Stephen H. Lockhart
- via Goldman Myla Lai
- via Paolo Pucci
- via Michel Lagarde
- via Robert F. Friel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $6,572,898
- 8 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,524 | $89.64 | $226,251 |
| Sep 15, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,524 | $365.00 | $921,260 |
| Sep 14, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,500 | $89.64 | $224,100 |
| Sep 14, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,500 | $355.00 | $887,500 |
| Sep 11, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,500 | $89.64 | $224,100 |
| Sep 11, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,500 | $345.00 | $862,500 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,817 | $83.47 | $235,135 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,817 | $340.81 | $960,062 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,818 | $83.47 | $235,218 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,818 | $340.81 | $960,403 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Option exercise | +2,500 | $89.64 | $224,100 |
| Sep 8, 2026 | Favorite Annette F Officer (Sr. VP & Chief HR Officer) | Open-market sale | −2,500 | $340.81 | $852,025 |
| Aug 11, 2026 | Robert W. McMahon Officer (SVP & Chief Financial Officer) | Option exercise | +794 | — | — |
| Aug 11, 2026 | Robert W. McMahon Officer (SVP & Chief Financial Officer) | Shares withheld for tax | −346 | $351.37 | $121,404 |
| Aug 11, 2026 | Robert W. McMahon Officer (SVP & Chief Financial Officer) | Option exercise | +6,355 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.